Authors' Reply
- PMID: 40009411
- DOI: 10.1097/CND.0000000000000509
Authors' Reply
Conflict of interest statement
Y. Harada is a salaried employee of UCB Pharma and receive stock and stock option from employment. The views and opinions expressed in this publication are solely those of the authors and do not necessarily reflect the official policy or position of company. D. B. Sanders has no conflict of interest related to this letter.
References
-
- Finsterer J. The course of double seronegative myasthenia during pregnancy may depend on diagnostic criteria and study design. J Clin Neuromuscul Dis. 2024;25:202–203.
-
- Harada Y, Bettin M, Juel VC, et al. Pregnancy in seronegative myasthenia gravis: a single-center case series. J Clin Neuromuscul Dis. 2023;25:85–88.
-
- Ducci RD, Lorenzoni PJ, Kay CS, et al. Clinical followup of pregnancy in myasthenia gravis patients. Neuromuscul Disord. 2017;27:352–357.
LinkOut - more resources
Full Text Sources